© 2021 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2021 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
June 11, 2021
May 25, 2021
What do we know about TD? What is on the horizon? Take the quiz to learn more.
May 10, 2021
How could drugs that block post-synaptic dopamine 2 receptors increase the risk for tardive dyskinesia over time?
April 16, 2021
Major risk factors for onset of tardive dyskinesia are considered.
March 31, 2021
What major challenges do patients with tardive dyskinesia face in their daily lives? Take the quiz and learn more.
March 30, 2021
The first study to gather unsolicited patient responses via social media finds 3 negative themes.
November 05, 2020
Learn about the results of the recent study on deutetrabenazine and the ways it is helping patients with tardive dyskinesia.
May 31, 2019
There are a few things that we all agree on, as reflected in a recent consensus statement.
May 30, 2019
Numbers don’t tell the whole story, but gaining a better sense of the frequency, risks, and impact on patients’ quality of life can help improve treatment efforts and enhance outcomes.
May 22, 2019
There are ways to prevent, manage, and treat TD, and this podcast will guide you through those steps from FDA-approved medications to off-label therapies.